Mark Rosenblum is a Partner at Company Ventures and leads Terrarium, the firm's healthcare venture studio. The firm announced his arrival on 23 May 2023 as an investment partner to lead healthcare investing. His firm biography and that announcement record prior roles as Managing Director at Redesign Health, a public market investor at Epoch Investment Partners, a healthcare equity research analyst at Morgan Stanley and healthcare investment banking at Jefferies, with an MBA from the Fuqua School of Business at Duke University and a BS in Finance from the University of Maryland. He is named as an Executive Officer and Director of Terrarium Inc. on its Form D filed 30 January 2025 and signed that filing as Chief Executive Officer.
Education
MBA, Fuqua School of Business, Duke University
BS in Finance, University of Maryland
Previous Experience
Managing Director, Redesign Health
Public market investor, Epoch Investment Partners
Healthcare equity research analyst, Morgan Stanley
Healthcare investment banking, Jefferies
Board Seats
Terrarium Inc. - Director
Career Timeline
2023
Announced as joining Company Ventures on 23 May 2023 in the firm's post 'Welcome Mark Rosenblum to Company Ventures', which describes him as an investment partner brought in to lead healthcare investing.
2025
Quoted as CEO of Terrarium in the firm's 19 February 2025 Terrarium launch announcement, and named as an Executive Officer and Director of Terrarium Inc. on its Form D filed 30 January 2025, which he signed as Chief Executive Officer.